1257832-74-8Relevant articles and documents
DEUTERATED CFTR POTENTIATORS
-
Paragraph 128, (2017/04/11)
This invention relates to compounds of Formula (I):and pharmaceutically acceptable salts thereof, wherein each X and each R is defined within. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
HETEROCYCLIC ANTIVIRAL COMPOUNDS
-
Page/Page column 45, (2010/12/29)
Compounds having the formula I wherein wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.